(Q44704634)

English

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

scientific article published in November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d (English)

1 reference

Europe PubMed Central

5 December 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

double-blind clinical trial

1 reference

based on heuristic

inferred from title

author name string

Michael H Davidson

1

1 reference

Europe PubMed Central

5 December 2017

Joanne Palmisano

2

1 reference

Europe PubMed Central

5 December 2017

Helene Wilson

3

1 reference

Europe PubMed Central

5 December 2017

Charles Liss

4

1 reference

Europe PubMed Central

5 December 2017

Mary R Dicklin

5

1 reference

Europe PubMed Central

5 December 2017

publication date

1 November 2003

1 reference

Europe PubMed Central

5 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

5 December 2017

25

1 reference

Europe PubMed Central

5 December 2017

11

1 reference

Europe PubMed Central

5 December 2017

2738-2753

1 reference

Europe PubMed Central

5 December 2017

Results of recent large cholesterol-lowering trials and implications for clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing dyslipidemia in the high-risk patient

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Meeting national cholesterol education goals in clinical practice--a comparison of lovastatin and fluvastatin in primary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in serum lipids when fluvastatin is substituted for lovastatin in the same doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-Blind Comparison of the Efficacy and Tolerability of Simvastatin and Fluvastatin in Patients with Primary Hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial to assess effectiveness and cost in clinical practice: rationale and design of the Cholesterol Reduction Intervention Study (CRIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol lowering in the elderly. Results of the Cholesterol Reduction in Seniors Program (CRISP) pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980330-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80330-2

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44704634&oldid=2098835330"